|
COPYRIGHT 2004 Asia Pulse Pty Ltd
(Full text of a statement, contact details below)
ADELAIDE, March 30 /MediaNet International-AsiaNet/ -- Bionomics Limited (ASX:BNO, US OTC:BMICY) and Southern Cross University announced today that they had established a collaboration to discover new drugs targeting epilepsy and anxiety.
Under the arrangement, Southern Cross University will provide Bionomics with extracts from its collection of Australian-based natural products, together with expertise in natural products chemistry. Bionomics will screen these natural products for activity against biological targets associated with epilepsy and anxiety and utilize Southern Cross Universitys natural products library and chemistry expertise to support its drug discovery program.
Bionomics is pleased to build out its network of drug discovery collaborators with Southern Cross University, stated Dr Deborah Rathjen, CEO and Managing Director of Bionomics. Our collaboration with Southern Cross University provides Bionomics with access to a unique collection of Australian-based natural products and broadens the opportunity to discover new drugs for epilepsy and...
Read the full article for free courtesy of your local library.
|
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
